List of Excipients in API ibuprofen capsules 200 mg
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing ibuprofen capsules 200 mg
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 | AMMONIA |
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 | FD&C GREEN NO. 3 |
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 | FERROSOFERRIC OXIDE |
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 | GELATIN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for ibuprofen capsules 200 mg
Excipient focus: AMMONIA
ibuprofen capsules 200 mg drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C GREEN NO. 3
ibuprofen capsules 200 mg drug variants containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
ibuprofen capsules 200 mg drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
ibuprofen capsules 200 mg drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
ibuprofen capsules 200 mg drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
ibuprofen capsules 200 mg drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
ibuprofen capsules 200 mg drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
ibuprofen capsules 200 mg drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
ibuprofen capsules 200 mg drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOOLEATE
ibuprofen capsules 200 mg drug variants containing SORBITAN MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing SORBITAN MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
ibuprofen capsules 200 mg drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
ibuprofen capsules 200 mg drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | ibuprofen capsules 200 mg | 49483-133 |
| A-S Medication Solutions | ibuprofen capsules 200 mg | 50090-3507 |
| HART Health | ibuprofen capsules 200 mg | 50332-0130 |
| >Company | >Ingredient | >NDC |
ibuprofen capsules 200 mg drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links